WallStreetZenWallStreetZen

NASDAQ: STLN
Starling Oncology Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Starling Oncology earnings were -$40.8M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest STLN earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$8.2M, up 293.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, STLN reported annual earnings of -$60.6M, with -6.3% growth.

STLN earnings history

Current Revenue
$587.2M
Current Earnings
-$40.8M
Current Profit Margin
-7%

STLN Return on Equity

Current Company
N/A
Current Industry
-48.3%
Current Market
29.1%

STLN Return on Assets

Current Company
-24.2%
Current Industry
6.9%
STLN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when STLN announces earnings.

STLN Return on Capital Employed

Current Company
-39.86%
Current Industry
13.5%
STLN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

STLN vs Medical Care Facility Stocks

TickerEBITDAEarningsY/Y EarningsEPS
STLN-$26.40M-$40.83MN/A-$50,304.75
MCTA$365.34k-$22.65k-100.00%$0.00
CYH$1.60B$252.00M-10.19%$1.87
AUNA$295.43M$20.04M-53.85%$0.27
GMRSN/AN/AN/AN/A
View Top Medical Care Facility Stocks

Starling Oncology Earnings Reports & History FAQ

What were Starling Oncology's earnings last quarter?

On STLN's earnings call on Aug 6, 2026, Starling Oncology (NASDAQ: STLN) reported Q2 2026 earnings per share (EPS) of -$0.08, up 46.67% year over year. Total STLN earnings for the quarter were -$8.24 million. In the same quarter last year, Starling Oncology's earnings per share (EPS) was -$0.15.

If you're new to stock investing, here's how to buy Starling Oncology stock.

Is Starling Oncology profitable or losing money?

As of the last Starling Oncology earnings report, Starling Oncology is currently losing money. Starling Oncology's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$40.83 million, a 37.92% decrease year over year.

What was STLN's earnings growth in the past year?

As of Starling Oncology's earnings date in Aug 6, 2026, Starling Oncology's earnings has grown year over year. STLN earnings in the past year totalled -$40.83 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.